Browsing by Author Brown, Ross

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2004B7+ T Cells In Myeloma: An Acquired Marker Of Prior Chronic Antigen Presentation.Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Sze, Daniel; Brown, Ross; Murray, Allan; Pope, Belinda; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; PharmacyB7+ T Cells In Myeloma: An Acquired Marker Of Prior Chronic Antigen Presentation., Leukemia & lymphoma, vol.45,(2),2004,pp 363-371
2012CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells T cells and are associated with poor prognosisGibson, John; Hart, Derek; Joshua, Douglas; Brown, Ross; Favaloro, James; Fromm, Phillip D; Joy Ho, P; Karieshma, Kabani; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineCD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells T cells and are associated with poor prognosis, Blood, vol.120, 10, 2012,pp 2055-2063
2004Either Interleukin-12 Or Interferon-γ Can Correct The Dendritic Cell Defect Induced By Transforming Growth Factor β₁ In Patients With Myeloma.Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Sze, Daniel; Brown, Ross; Hart, Derek; Murray, Allan; Pope, Belinda; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; PharmacyEither Interleukin-12 Or Interferon-γ Can Correct The Dendritic Cell Defect Induced By Transforming Growth Factor β₁ In Patients With Myeloma., British Journal of Haematology, vol.125,(2),2004,pp 743-748
2013Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balanceBryant, Christian; Fromm, Phillip; Hart, Derek; Ho, Phoebe (Joy); Iland, Harry; Joshua, Douglas; Aklilu, Esther; Brown, Ross; Favaloro, James; Gibson, J; Nassif, N; Suen, Hayley; Woodland, N. B.; Yang, S; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineLong-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance, Blood Cancer Journal, vol.3, N/A, 2013,pp 1-7
2014Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myelomaHart, Derek; Joshua, Douglas; Brown, Ross; Favaloro, James; Fromm, Phillip D; Gibson, John; Ho, P J; Liyadipitiya, Tulita; Nassif, Najah; Suen, Hayley; Weatherburn, Claire; Woodland, N. B.; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineMyeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma, Leukemia & Lymphoma, vol.55, 12, 2014,pp 2893-2900
2014Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive stateFromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Aklilu, Esther; Brown, Ross; Favaloro, James; Gibson, John; Khoo, Liane; Suen, Hayley; Yang, Shihong; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: MedicineMyeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state, Leukemia & Lymphoma, vol.55, 5, 2014,pp 1090-1098
2012Thalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trialBrown, Ross; Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Daniher, Daniel; Jeffels, Melinda; Spencer, Andrew; Pharmacy; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineThalidomide consolidation improves progression-free survival in myeloma with normal but not up-regulated expression of fibroblast growth factor receptor 3: analysis from the Australasian Leukaemia and Lymphoma Group MM6 clinical trial, Leukemia and Lymphoma, vol.53, 9, 2012,pp 1728-1734
2012Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myelomaJoshua, Douglas; Brown, Ross; Favaloro, James; Gibson, John; Ho, P. Joy; Suen, Hayley; Yang, Shihong; Central Clinical School: MedicineTrogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma, OncoImmunology, vol.1, 9, 2012,pp 1658-1660